Clinical Trials Notification (CTN)
A copy of the eCTN registration must be included with the application.
Once the notification process has been completed, the approval letter should be submitted to the Research Governance Office via ERM. The CTN lodgement may occur after governance authorisation for the study has been issued. If this occurs, the CTN registration notification should be submitted via ERM as a post-authorisation notification. For CTN details please refer to the CTN Information Sheet.
Metro North Health approving authority (for studies to be conducted at Metro North)
| Approving authority | Metro North Hospital and Health Service |
| Name | Adjunct Professor Jackie Hanson |
| Position | Chief executive, Metro North Health |
| Phone number | 07 3647 9550 |
| MetroNorthResearch-RGO@health.qld.gov.au |
Radiation Dose and Risk Assessment Report
For all studies involving ionising radiation, a radiation dose and risk assessment report is required.
More information on this report
Standard Form of Indemnity
Medicines Australia Form of Indemnity for Clinical Trials
Metro North Hospital and Health Service (ABN 18 496 277 942), Block 7 Level 14, Butterfield Street, Herston, Qld 4029, Australia
Other supporting documentation
Depending on the clinical trial, other documentation may be required.
- Office of the Gene Technology Regulator (OGTR), licence for dealings with a Genetically Modified Organism (GMO);
- Institutional Biosafety Committee (IBC) approval
- NHMRC Embryo Research Licensing Committee